Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
Open Access
- 19 March 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (13)
Abstract
The design of protein–protein interfaces using physics-based design methods such as Rosetta requires substantial computational resources and manual refinement by expert structural biologists. Deep learning methods promise to simplify protein–protein interface design and enable its application to a wide variety of problems by researchers from various scientific disciplines. Here, we test the ability of a deep learning method for protein sequence design, ProteinMPNN, to design two-component tetrahedral protein nanomaterials and benchmark its performance against Rosetta. ProteinMPNN had a similar success rate to Rosetta, yielding 13 new experimentally confirmed assemblies, but required orders of magnitude less computation and no manual refinement. The interfaces designed by ProteinMPNN were substantially more polar than those designed by Rosetta, which facilitated in vitro assembly of the designed nanomaterials from independently purified components. Crystal structures of several of the assemblies confirmed the accuracy of the design method at high resolution. Our results showcase the potential of deep learning–based methods to unlock the widespread application of designed protein–protein interfaces and self-assembling protein nanomaterials in biotechnology.Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (INV-010680)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U54AI170856)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (1P01AI167966)
This publication has 74 references indexed in Scilit:
- ProGen2: Exploring the boundaries of protein language modelsCell Systems, 2023
- Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trialeClinicalMedicine, 2022
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021
- Structure-based design of novel polyhedral protein nanomaterialsCurrent Opinion in Microbiology, 2021
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionCell, 2021
- Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Cell, 2020
- Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous AmidationAngewandte Chemie International Edition, 2020
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial VirusCell, 2019
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bondsProtein Science, 2012